Human senescent fibroblasts trigger fibrogenic reaction in the lungs of...
A new research paper was published on the cover of Aging (listed by MEDLINE/PubMed as "Aging (Albany NY)" and "Aging-US" by Web of Science) Volume 15, Issue 14, entitled, "Human senescent fibroblasts...
View ArticleUVA scientists develop new approach to machine learning for identifying heart...
University of Virginia scientists have developed a new approach to machine learning – a form of artificial intelligence – to identify drugs that help minimize harmful scarring after a heart attack or...
View ArticleU-M study reveals potential pathway to reverse lung fibrosis
The most common type of lung fibrosis -; scarring of the lungs -- is idiopathic, meaning of unknown cause.
View ArticleNew study offers hope for extending ovarian healthspan and function
A woman's ovaries are like a factory where eggs grow and produce hormones that regulate everything from menstruation and pregnancy to bone density and mood.
View ArticleIn silico docking of clinically approved drugs against the SARS-CoV-2...
Announcing a new article publication for BIO Integration journal. Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), first identified in China in December 2019, rapidly spread worldwide,...
View ArticleBlocking Piezo2 may offer a new therapeutic approach for pulmonary fibrotic...
Researchers have found a potential new way to slow the progression of lung fibrosis and other fibrotic diseases by inhibiting the expression or function of Piezo2, a receptor that senses mechanical...
View ArticleAdvancing pulmonary fibrosis treatment through targeted drug delivery
Announcing a new article publication for BIO Integration journal. Pulmonary fibrosis (PF) is a progressive interstitial lung disease characterized by excessive extracellular matrix deposition and...
View ArticleGlobal clinical trial tests two anti-inflammatory drugs for long COVID
Spanning four continents and enrolling hundreds of people, a new clinical trial will test the effectiveness of two anti-inflammatory medicines as potential treatments for long COVID, scientists from...
View ArticleAI-designed drug shows early promise for lung fibrosis patients in clinical...
Researchers report that rentosertib, an AI-discovered TNIK inhibitor, showed promising safety and potential to improve lung function in patients with idiopathic pulmonary fibrosis in a 12-week phase 2a...
View ArticleQureight's synthetic study arms validate clinical efficacy in pioneering rare...
Qureight, a deep-learning analytics company accelerating drug development through AI-powered data curation, today announced that its digitally-twinned synthetic control arm has been used in a...
View Article